Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
about
Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation.Development and Evaluation of 18F-IRS for Molecular Imaging Mutant EGF Receptors in NSCLC.Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab.Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic MiceComparative transcriptome profiling of an SV40-transformed human fibroblast (MRC5CVI) and its untransformed counterpart (MRC-5) in response to UVB irradiation.Membrane-Tethered Intracellular Domain of Amphiregulin Promotes Keratinocyte Proliferation.MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation.Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells.Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcomaIdentification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer propertiesInsulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.EGF receptor signaling, phosphorylation, ubiquitylation and endocytosis in tumors in vivo.A nonimmune function of T cells in promoting lung tumor progression.The Role of Hippo Pathway in Cancer Stem Cell Biology.Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors.The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
P2860
Q26798882-D18F7D93-7562-41B1-877F-5C0140CDAA1EQ27853131-FC6EF7E2-7AD1-4DF4-A8EA-5F673350DD8FQ33731197-D3108D90-311F-4215-BAFF-054DDCE5E7C8Q33784735-E724ED74-58FF-4E0F-AB9B-2C1BA754A0C2Q33972424-9E3D0910-675B-472A-806E-3371808F9414Q34205052-D6BAC04F-2072-4985-9675-D40FAE634B96Q34627751-32228911-2097-44D6-A925-56F902B840BCQ34982814-8894C2CA-5420-4747-A48F-105DE8A79D3DQ36677686-38D0C10B-2D0B-4CCC-ACD3-AACAD89F6F08Q37268998-98A661B1-B396-42CE-B084-6DF41D709628Q38615458-8D4FA501-5CAB-4351-B850-98EDE371FC07Q39509236-357731CF-E32C-43E2-A202-0A43C508B5D8Q39660371-61038A91-B7AB-4C38-ABBE-FEA213EE95D6Q40996325-5EB46478-9CEB-4221-812F-B00203654B52Q41580211-7A4C62DD-755B-4FDD-AB31-56494CDC1C3DQ43807392-9496552C-F0D2-444B-8D62-0BE8EC2ED8B6Q44497412-24889028-E2DB-46D1-866F-8309F72719AEQ47156089-891B3E9D-9EAA-41FF-9FD4-CD6AB00D3D5AQ47643448-3913FB56-FE6E-4CDC-B3CC-45028B880CD8Q50078696-ED3F95DC-AD23-4076-9A01-61109E4563D2Q53303546-BD6B98EE-F935-41CD-83AD-3510B4B53419Q54423334-BB7943B9-2F61-47F6-8986-A114B6E2E6A0
P2860
Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Amphiregulin promotes BAX inhi ...... n non-small-cell lung cancers.
@ast
Amphiregulin promotes BAX inhi ...... n non-small-cell lung cancers.
@en
type
label
Amphiregulin promotes BAX inhi ...... n non-small-cell lung cancers.
@ast
Amphiregulin promotes BAX inhi ...... n non-small-cell lung cancers.
@en
prefLabel
Amphiregulin promotes BAX inhi ...... n non-small-cell lung cancers.
@ast
Amphiregulin promotes BAX inhi ...... n non-small-cell lung cancers.
@en
P2093
P2860
P50
P356
P1433
P1476
Amphiregulin promotes BAX inhi ...... in non-small-cell lung cancers
@en
P2093
Amandine Hurbin
Carole Niang
Marie C Favrot
P2860
P304
P356
10.1038/MT.2009.226
P577
2009-10-13T00:00:00Z